Alcon Inc (ALC)
85.53
+0.03
(+0.04%)
USD |
NYSE |
Nov 21, 16:00
85.53
0.00 (0.00%)
After-Hours: 20:00
Alcon Price to Book Value: 2.020 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.019 |
| November 19, 2024 | 2.018 |
| November 18, 2024 | 2.027 |
| November 15, 2024 | 2.011 |
| November 14, 2024 | 2.012 |
| November 13, 2024 | 2.066 |
| November 12, 2024 | 2.052 |
| November 11, 2024 | 2.180 |
| November 08, 2024 | 2.187 |
| November 07, 2024 | 2.187 |
| November 06, 2024 | 2.160 |
| November 05, 2024 | 2.183 |
| November 04, 2024 | 2.177 |
| November 01, 2024 | 2.168 |
| October 31, 2024 | 2.172 |
| October 30, 2024 | 2.203 |
| October 29, 2024 | 2.232 |
| October 28, 2024 | 2.241 |
| October 25, 2024 | 2.226 |
| October 24, 2024 | 2.229 |
| October 23, 2024 | 2.232 |
| October 22, 2024 | 2.235 |
| October 21, 2024 | 2.228 |
| October 18, 2024 | 2.247 |
| October 17, 2024 | 2.232 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.251 |
| October 15, 2024 | 2.282 |
| October 14, 2024 | 2.296 |
| October 11, 2024 | 2.284 |
| October 10, 2024 | 2.275 |
| October 09, 2024 | 2.278 |
| October 08, 2024 | 2.265 |
| October 07, 2024 | 2.254 |
| October 04, 2024 | 2.297 |
| October 03, 2024 | 2.317 |
| October 02, 2024 | 2.341 |
| October 01, 2024 | 2.341 |
| September 30, 2024 | 2.364 |
| September 27, 2024 | 2.347 |
| September 26, 2024 | 2.334 |
| September 25, 2024 | 2.326 |
| September 24, 2024 | 2.317 |
| September 23, 2024 | 2.308 |
| September 20, 2024 | 2.296 |
| September 19, 2024 | 2.316 |
| September 18, 2024 | 2.276 |
| September 17, 2024 | 2.288 |
| September 16, 2024 | 2.323 |
| September 13, 2024 | 2.320 |
| September 12, 2024 | 2.373 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.008
Minimum
Mar 23 2020
2.373
Maximum
Sep 12 2024
1.826
Average
1.838
Median
Price to Book Value Benchmarks
| AC Immune SA | 2.101 |
| CRISPR Therapeutics AG | 2.037 |
| Addex Therapeutics Ltd | 0.6249 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 1.192 |
Price to Book Value Related Metrics
| PE Ratio | 36.55 |
| PS Ratio | 4.356 |
| PEG Ratio | 0.2285 |
| Price | 85.53 |
| Earnings Yield | 2.74% |
| Market Cap | 42.30B |
| PEGY Ratio | 0.2280 |
| Operating PE Ratio | 34.68 |
| Normalized PE Ratio | 36.55 |